Home > Harms arising from the use of synthetic cannabinoid products.

Cunningham, Andrew and Gallegos, Ana and Francis, Will and Evans-Browns, Michael (2015) Harms arising from the use of synthetic cannabinoid products. European Monitoring Centre for Drugs and Drug Addiction.

[img]
Preview
PDF (Factsheet) - Published Version
779kB

‘Synthetic cannabinoids’ or, more correctly, synthetic cannabinoid receptor agonists (SCRAs), are synthetic chemicals that mimic the effects of the natural psychoactive substances found in cannabis. ‘Legal high’ products containing SCRAs have been sold as herbal smoking mixtures since at least 2006. Recently, new products containing SCRAs have emerged such as a ‘resin’ resembling cannabis resin and liquids suitable for use in electronic cigarettes. The products have been marketed in innovative ways and may be sold openly on the internet and in specialist ‘smoke’ shops.

Item Type
FactSheet
Publication Type
International
Drug Type
Cannabis, Prescription/Over the counter
Intervention Type
Harm reduction
Date
September 2015
Publisher
European Monitoring Centre for Drugs and Drug Addiction
EndNote
Accession Number
HRB (Electronic Only)
Related (external) link

Repository Staff Only: item control page